Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies.

NPJ Breast Cancer · 2021 · PMC7881093 · PMID 33579962

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

For AIs, the HR showed a trend towards longer PFS for patients with non-VM versus those with VM, but the 95% CI crossed 1.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

For AIs, the OS was statistically significantly better for non-VM versus VM patients and although the PFS did not reach statistical significance, the hazard ratio was similar to tamoxifen, suggesting that the effects of AIs are consistent with SERM.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.